|
Just two of 190 cities had low level of air pollution in 2010
Hindustan Times Aaron Cohen, who headed the GBD expert group on air pollution, described the situation in India as “grave” and said that that air pollution causes about 20 % of lung cancer and six percent of high blood pressure deaths in India. The CPCB report shows … |
Beacon NewsFlashes – March 6, 2013 – The Myeloma Beacon
|
Beacon NewsFlashes – March 6, 2013
The Myeloma Beacon The study included 47 patients with lymphoma or myeloma who underwent a stem cell transplant. Half of the patients received G-CSF every day, while the other half received G-CSF every other day, after stem cell transplantation until their white blood … |
Biogen Idec to Present New Data on Diverse Neurological Portfolio at 65th AAN … – Investor's Business Daily
|
Biogen Idec to Present New Data on Diverse Neurological Portfolio at 65th AAN …
Investor’s Business Daily The company will also present results from the investigational trials of its late-stage MS pipeline, including TECFIDERA™ (dimethyl fumarate), peginterferon beta-1a and daclizumab high-yield process (DAC HYP). As part of the company’s overall … |
Biogen Idec to Present New Data on Diverse Neurological Portfolio at 65th AAN … – Financial Post
|
Biogen Idec to Present New Data on Diverse Neurological Portfolio at 65th AAN …
Financial Post The company will also present results from the investigational trials of its late-stage MS pipeline, including TECFIDERA™ (dimethyl fumarate), peginterferon beta-1a and daclizumab high-yield process (DAC HYP). As part of the company’s overall … |
Biogen Idec to Present New Data on Diverse Neurological Portfolio at 65th AAN … – Business Wire (press release)
|
Biogen Idec to Present New Data on Diverse Neurological Portfolio at 65th AAN …
Business Wire (press release) The company will also present results from the investigational trials of its late-stage MS pipeline, including TECFIDERA™ (dimethyl fumarate), peginterferon beta-1a and daclizumab high-yield process (DAC HYP). As part of the company’s overall … |
Biogen Idec to Present New Data on Diverse Neurological Portfolio at 65th AAN … – MarketWatch (press release)
Biogen Idec to Present New Data on Diverse Neurological Portfolio at 65th AAN …MarketWatch (press release)… (prolonged-release fampridine tablets). The company will also present results from the investigational trials of its late-stage MS pipeline,…
From Heart Failure to Triumph: The Story of Ethan Mullis – Beach Carolina Magazine
 Beach Carolina Magazine |
From Heart Failure to Triumph: The Story of Ethan Mullis
Beach Carolina Magazine Ethan subsequently experienced heart failure before completing his first week of life, underwent corrective heart surgery at just three days old and went into cardiac arrest before six weeks of age. Fortunately, Ethan’s heart defect was detected via … |
American Red Cross, Keebler® Keep Blood Donation Sweet – Daily Markets (press release)
 WNYT |
American Red Cross, Keebler® Keep Blood Donation Sweet
Daily Markets (press release) WASHINGTON, March 6, 2013 /PRNewswire-USNewswire/ – The American Red Cross and Keebler are continuing their partnership to sweeten the deal for donors who give lifesaving blood for those in need. American Red Cross Cross Needs Blood DonationsWBIW.com Madison Red Cross to present ‘Dracula’ ballet tickets to lucky blood donorsExaminer.com |
Shortly before death of Heydar Aliyev Azerbaijani authorities carried out an … – Panorama.am
|
Shortly before death of Heydar Aliyev Azerbaijani authorities carried out an …
Panorama.am Ambassador of Panama to the Organization of American States Guillermo Koches said last week that brain death was recorded with Chavez in late December, according to the site “tvrain.ru”. The article notes that this is not the first time that the leader … |
Rose-Leigh is ready for transplant – Independent Online
Independent OnlineRose-Leigh is ready for transplantIndependent OnlineDurban – Nine-year-old Rose-Leigh Usher, the Wentworth girl fighting a rare, aggressive cancer, could undergo a potentially life-saving stem cell transplant within four to six weeks,…